Note 14 -
Net loss per share
The
following tables sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three
months ended March 31, 2025 and 2024:
| Schedule of basic and diluted net loss per share | |
| |
| | |
Three Months Ended March 31, | |
| | |
2025 | | |
2024 | |
| Numerator – basic & diluted: | |
| | | |
| | |
| Net loss attributable to common stockholders, basic and diluted | |
$ | (10,554,271 | ) | |
$ | (9,150,003 | ) |
| Denominator: | |
| | | |
| | |
| Weighted-average number of shares outstanding, basic and diluted | |
| 372,541,173 | | |
| 307,423,873 | |
| | |
| | | |
| | |
| Net loss per share attributable to common stockholders, basic and diluted | |
$ | (0.03 | ) | |
$ | (0.03 | ) |
The
following potentially dilutive shares were not included in the calculation of diluted shares outstanding for the periods presented as
the effect would have been anti-dilutive at March 31, 2025 and 2024:
| Schedule of anti-dilutive shares | |
| | |
| |
| | |
March 31, | | |
March 31, | |
| | |
2025 | | |
2024 | |
| Outstanding warrants | |
| 19,789,379 | | |
| 19,789,379 | |
| Outstanding stock options | |
| 40,366,156 | | |
| 39,217,071 | |
| Total dilutive shares | |
| 60,155,535 | | |
| 59,006,450 | |
|